William J Chase's Net Worth

$58.9 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is William J Chase?

William J Chase has an estimated net worth of $58.9 Million. This is based on reported shares across multiple companies, which include AbbVie Inc., Intellia Therapeutics, Inc., and GRAIL, Inc..

SEC CIK

William J Chase's CIK is 0001563572

Past Insider Trading and Trends

2013 was William J Chase's most active year for acquiring shares with 8 total transactions. William J Chase's most active month to acquire stocks was the month of January. 2013 was William J Chase's most active year for disposing of shares, totalling 10 transactions. William J Chase's most active month to dispose stocks was the month of January. 2019 saw William J Chase paying a total of $2,045,920.00 for 152,712 shares, this is the most they've acquired in one year. In 2018 William J Chase cashed out on 191,735 shares for a total of $17,071,052.26, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AbbVie Inc. (ABBV) Snapshot price: $193.15

EVP, Finance & Administration

William J Chase owns 169,552 units of Common stock, $0.01 par value which is worth $32,748,968.80.acquired a total of 456,089 shares in AbbVie Inc. at a cost of $4,776,495.51, William also disposed a total of 376,697 shares of AbbVie Inc. equalling to $30,388,963.40.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.85%
30.4K
$67.30
$2,045,920.00
169.55K
Jun 26
Form 4
-16.39%
-27.28K
$79.41
-$2,165,987.16
139.15K
Feb 28
Form 4
+58.71%
61.56K
—
—
166.43K
Feb 21
Form 4
-36.39%
-60.00K
$90.00
-$5,400,000.00
104.86K
Dec 12
Form 4
-28.88%
-66.94K
$71.70
-$10,831,712.98
164.86K
Feb 28 - Mar 1
Form 4
+26.29%
48.26K
—
—
231.8K
Feb 15
Form 4
—
0
$46.99
-$1,406,911.00
183.54K
May 18
Form 4
-17.97%
-40.21K
$62.22
-$2,501,990.64
183.54K
Feb 28
Form 4
+29.81%
51.38K
—
—
223.75K
Feb 16
Form 4
—
0
$43.24
-$210,540.00
172.37K
Dec 2
Form 4
-20.94%
-45.66K
$56.00
-$2,556,848.00
172.37K
Feb 29
Form 4
—
0
—
—
0
Feb 18
Form 4
-7.82%
-18.49K
$60.51
-$1,118,911.48
218.03K
Feb 27 - Feb 28
Form 4
+31.05%
56.04K
—
—
236.52K
Feb 19
Form 4
—
0
$46.04
-$373,159.02
180.07K
Dec 22
Form 4
-7.13%
-13.82K
$51.43
-$710,766.10
180.07K
Feb 28 - Mar 3
Form 4
+38.37%
53.77K
—
—
193.89K
Feb 20
Form 4
+1.06%
1.46K
$44.47
-$70,460.12
140.12K
Dec 19
Form 4
-3.65%
-5.26K
$36.73
-$193,199.80
138.66K
Feb 28
Form 4
+59.68%
53.79K
$37.58
-$109,432.96
143.92K
Feb 14 - Feb 19
Form 4
+0.42%
379
$34.67
-$8,468.63
90.13K
Feb 7
Form 3
—
0
—
—
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75

Investor

William J Chase owns 26,693 units of Common Stock which is worth $527,186.75. In the year 2023 William J Chase acquired a total of 19,893 shares in Intellia Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.82%
7.74K
—
—
26.69K
Jun 12
Form 4
+9.68%
1.67K
—
—
18.96K
Jun 14
Form 4
+154.16%
10.48K
—
—
17.28K
Apr 14
Form 3
—
0
—
—
0
No matching records found

GRAIL, Inc. No price found

Investor

William J Chase owns 26,470 units of Common Stock. In the year 2024 William J Chase filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
26.47K
—
—
26.47K
Jun 25
Form 3
—
0
—
—
0
No matching records found